Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Real World Development: Increasing value for patients

June 30, 2010 Research and Development Kinapse, drug development

The traditional drug development paradigm is protracted and costly, with many products failing to deliver commercial or clinical success.We propose …
Feature

Boehringer cheered by diabetes data

June 28, 2010 Research and Development Boehringer, DPP-4, diabetes, linagliptin

Boehringer Ingelheim has been cheered by phase III data showing its new oral once-daily type II diabetes tablet linagliptin significantly …
News

New anti-clotting drugs: stopping the silent killers

June 28, 2010 Research and Development, Sales and Marketing Pradaxa, VTE, Xarelto, atrial fibrilation, thrombosis

Blood clots are a major killer, but the threat they pose is poorly understood by the general public compared to …
Feature

Sanofi licences novel oral anti-diabetic treatment

June 25, 2010 Research and Development, Sales and Marketing Metabolex, Sanofi-Aventis, diabetes

Sanofi-Aventis has signed an exclusive worldwide licensing agreement with US-based diabetes specialist Metabolex for a novel oral anti-diabetic treatment. MBX-2982 …
News

Merck moves tropical disease drug into phase II

June 25, 2010 Research and Development Chagas disease, Merck & Co, Noxafil, tropical disease

Merck & Co is to see whether its oral antifungal agent Noxafil (posaconazole) can be used in chronic cases of …
News

Clavis Pharma appoints Athos Gianella-Borradori

June 24, 2010 Research and Development Clavis Pharma, appointment, research and development

Athos Gianella-Borradori has joined clinical stage oncology drug development company Clavis Pharma as chief medical officer. His appointment to the …
Appointment

AstraZeneca and Targacept begin depression trials

June 24, 2010 Research and Development AstraZeneca, Targacept, depression

AstraZeneca and Targacept have begun enrolling patients in phase III trials for TC-5214, a new treatment for depression. The new …
News

Prix Galien shortlist unveiled

June 24, 2010 Research and Development prix galien

The shortlist of innovative medicines which will compete for two prestigious UK Prix Galien medals later this year has been …
News
UKCRMI

Plans for UK’s research hub unveiled

June 23, 2010 Research and Development Cancer Research UK, MRC, UCL, UKCMRI, Wellcome, biomedical

The vision for a new UK biomedical research and innovation centre which will be the biggest in Europe has been …
News

Prosensa and GSK add to muscular dystrophy alliance

June 23, 2010 Research and Development GlaxoSmithKline, Prosensa, muscular dystrophy

GSK has extended its research alliance with biotech company Prosensa in the field of muscular dystrophy. Netherlands-based Prosensa focuses on …
News
George Osborne

Mixed reaction for Osborne’s first Budget

June 23, 2010 Research and Development, Sales and Marketing biotech, pharma, tax, tax relief

George Osborne’s first Budget as chancellor has had a mixed reception from the pharma and biotech sectors. The BioIndustry Association …
News

PRA bolsters late phase services

June 23, 2010 Research and Development CRO, PRA, appointment, research and development

Contract research organisation PRA International has appointed Hani Zaki senior VP of its Late Phase Services business. Late Phase Services …
Appointment

Sanofi signs microRNA therapy deal

June 23, 2010 Research and Development RNA, Regulus, Sanofi-Aventis

Sanofi-Aventis has entered into a global strategic alliance with US-based therapeutics firm Regulus to develop and commercialise microRNA therapeutics. Regulus …
News

Medical Affairs at the Centre of Life Sciences Innovation

June 22, 2010 Research and Development Kinapse, Medical Affairs, Real World Development, consulting, outsourcinf

In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …
Feature
Thought Leadership

Europe must move on from ‘simplistic’ pricing

June 22, 2010 Research and Development Europe, hta, pricing, pricing & Reimbursement

GSK chief executive Andrew Witty has called on European governments to scrap outdated pricing systems and embrace newer methods, in …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025